Ascendis Pharma A (ASND) Inventory (2021 - 2026)

Ascendis Pharma A has reported Inventory for 6 years, with the latest figure at $368.0 million in Q1 2026.

• Quarterly Inventory rose 19.38% year-over-year to $368.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $368.0 million (up 19.38% YoY) and the FY2025 annual result came in at $351.0 million, up 11.12% from the prior year.
• Inventory advanced to $368.0 million in Q1 2026 per ASND's latest filing, from $351.0 million in the prior quarter.
• Over five years, Inventory peaked at $368.0 million in Q1 2026 and troughed at $103.7 million in Q1 2022.
• A 5-year average of $240.0 million and a median of $252.8 million in 2024 frame the typical range for Inventory.
• The sharpest annual moves came in 2023 and 2025: Inventory jumped 96.39% in 2023, then climbed 11.12% in 2025.
• Over 5 years, Inventory stood at $133.3 million in 2022, then soared by 68.62% to $224.8 million in 2023, then soared by 40.52% to $315.9 million in 2024, then increased by 11.12% to $351.0 million in 2025, then gained by 4.85% to $368.0 million in 2026.
• According to Business Quant data, Inventory over the past three periods registered $368.0 million, $351.0 million, and $353.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.